Cleared Traditional

K922896 - VITAL-PORT VASCULAR ACCESS SYSTEM W/ IN...

K922896 is an FDA 510(k) clearance for VITAL-PORT VASCULAR ACCESS SYSTEM W/ IN..., manufactured by Med Institute, Inc.. The device is a Class 2 General Hospital device with product code LJT cleared through the Traditional 510(k) pathway after a 277-day FDA review.

K922896 · Med Institute, Inc. · General Hospital
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Mar 1993
Decision
277d
Days
Class 2
Risk

K922896 is an FDA 510(k) clearance for the VITAL-PORT VASCULAR ACCESS SYSTEM W/ INJECTROL. Classified as Port & Catheter, Implanted, Subcutaneous, Intravascular (product code LJT), Class II - Special Controls.

Submitted by Med Institute, Inc. (West Lafayette, US). The FDA issued a Cleared decision on March 20, 1993 after a review of 277 days - an extended review cycle.

This device falls under the General Hospital FDA review panel, regulated under 21 CFR 880.5965 - the FDA general hospital device framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Standard predicate-based submission. Standard predicate reliance. This clearance follows a standard predicate-based equivalence path within the General Hospital review framework, consistent with the majority of Class II 510(k) submissions.

View all Med Institute, Inc. devices

FDA 510(k) Submission Details - K922896

510(k) Number K922896 FDA.gov
FDA Decision Cleared Substantially Equivalent - Special 510(k) (SESK)
Date Received June 16, 1992
Decision Date March 20, 1993
Days to Decision 277 days
Submission Type Traditional
Review Panel General Hospital (HO)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Regulatory Context
Review time vs. panel average
148d slower than avg
Panel avg: 129d · This submission: 277d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

LJT Device Classification - Class 2, Special Controls

Product Code LJT Port & Catheter, Implanted, Subcutaneous, Intravascular
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 880.5965
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most General Hospital devices follow this clearance model.

Regulatory Peers - LJT Port & Catheter, Implanted, Subcutaneous, Intravascular

All 126
Devices cleared under the same product code (LJT) and FDA review panel - the closest regulatory comparables to K922896.
LIFEPORT ATTACHABLE SYSTEM W/INDUCER KIT LPS 5555
K915273 · Strato Medical Corp. · Jul 1993
SNAP-LOCK MICROPORT - REVISED
K924505 · Strato Medical Corp. · Jun 1993
PHARMACIA DELTEC WINGED INFUSION SET
K923019 · Pharmacia Deltec, Inc. · Apr 1993
IPI IMPORT
K922419 · Pudenz-Schulte Medical Research Corp. · Nov 1992
PLASTIC ATTACHABLE DUAL PORT
K912702 · Davol, Inc. · Sep 1991
STRATO PORT INTRODUCER KT(10 FR) LPS 5015/MODIFIED
K905838 · Strato Medical Corp. · Apr 1991